Africa Israel, Polar to build US theme park

Africa Israel and Polar would each own 17 stakes. Other partners in the project include HFZ Capital Group, Safeharbor Holdings.

By SETH FREEDMAN
April 3, 2006 07:35

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Africa Israel Investments and Polar International Real Estate Ltd. said on Sunday they raised $305 million to build the "Hard Rock Park" project, a music-themed amusement park, to be located in Myrtle Beach, South Carolina. Africa Israel and Polar would each own 17 percent stakes. Other partners in the project include HFZ Capital Group, Safeharbor Holdings. The 150-acre park will include 40 attractions and an amphitheater for live shows and cost a total of $370 to build. Construction is expected to begin this summer and the park was expected to open in Spring 2008.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS